Sedana Medical AB (publ) reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was SEK 153.87 million compared to SEK 122.87 million a year ago. Net loss was SEK 59.61 million compared to SEK 73.51 million a year ago.

Basic loss per share from continuing operations was SEK 0.6 compared to SEK 0.74 a year ago. Diluted loss per share from continuing operations was SEK 0.6 compared to SEK 0.74 a year ago.